1-adamantylimino(2,2-dimethylpropylidene)molybdenum;bis(3-bromo-1-(3-bromo-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol);(2,6-dichlorophenyl)imino-(2,2-dimethylpropylidene)tungsten;bis((2,6-dimethylphenyl)imino-(2,2-dimethylpropylidene)molybdenum);bis(2,5-dimethylpyrrol-1-ide);1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol;2-[4-methyl-2,6-di(propan-2-yl)phenyl]-6-[2,4,6-tri(propan-2-yl)phenyl]phenol;pyrrol-1-ide;1,1,1-trifluoro-2-methylpropan-2-ol
C152H197Br4Cl2F9Mo3N7O5W-3 — CID 158430533
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-adamantylimino(2,2-dimethylpropylidene)molybdenum;bis(3-bromo-1-(3-bromo-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol);(2,6-dichlorophenyl)imino-(2,2-dimethylpropylidene)tungsten;bis((2,6-dimethylphenyl)imino-(2,2-dimethylpropylidene)molybdenum);bis(2,5-dimethylpyrrol-1-ide);1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol;2-[4-methyl-2,6-di(propan-2-yl)phenyl]-6-[2,4,6-tri(propan-2-yl)phenyl]phenol;pyrrol-1-ide;1,1,1-trifluoro-2-methylpropan-2-ol
1-adamantylimino(2,2-dimethylpropylidene)molybdenum;bis(3-bromo-1-(3-bromo-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol);(2,6-dichlorophenyl)imino-(2,2-dimethylpropylidene)tungsten;bis((2,6-dimethylphenyl)imino-(2,2-dimethylpropylidene)molybdenum);bis(2,5-dimethylpyrrol-1-ide);1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol;2-[4-methyl-2,6-di(propan-2-yl)phenyl]-6-[2,4,6-tri(propan-2-yl)phenyl]phenol;pyrrol-1-ide;1,1,1-trifluoro-2-methylpropan-2-ol (PubChem CID 158430533) has the molecular formula C152H197Br4Cl2F9Mo3N7O5W-3 and a molecular weight of 3235.46 g/mol. Its IUPAC name is 1-adamantylimino(2,2-dimethylpropylidene)molybdenum;bis(3-bromo-1-(3-bromo-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol);(2,6-dichlorophenyl)imino-(2,2-dimethylpropylidene)tungsten;bis((2,6-dimethylphenyl)imino-(2,2-dimethylpropylidene)molybdenum);bis(2,5-dimethylpyrrol-1-ide);1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol;2-[4-methyl-2,6-di(propan-2-yl)phenyl]-6-[2,4,6-tri(propan-2-yl)phenyl]phenol;pyrrol-1-ide;1,1,1-trifluoro-2-methylpropan-2-ol.
Molecular Properties
| Compound Name | 1-adamantylimino(2,2-dimethylpropylidene)molybdenum;bis(3-bromo-1-(3-bromo-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol);(2,6-dichlorophenyl)imino-(2,2-dimethylpropylidene)tungsten;bis((2,6-dimethylphenyl)imino-(2,2-dimethylpropylidene)molybdenum);bis(2,5-dimethylpyrrol-1-ide);1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol;2-[4-methyl-2,6-di(propan-2-yl)phenyl]-6-[2,4,6-tri(propan-2-yl)phenyl]phenol;pyrrol-1-ide;1,1,1-trifluoro-2-methylpropan-2-ol |
|---|---|
| PubChem CID | 158430533 |
| Molecular Formula | C152H197Br4Cl2F9Mo3N7O5W-3 |
| Molecular Weight | 3235.46 g/mol |
| Exact Mass | 3234.80 |
| IUPAC Name | 1-adamantylimino(2,2-dimethylpropylidene)molybdenum;bis(3-bromo-1-(3-bromo-2-methyl-5,6,7,8-tetrahydronaphthalen-1-yl)-5,6,7,8-tetrahydronaphthalen-2-ol);(2,6-dichlorophenyl)imino-(2,2-dimethylpropylidene)tungsten;bis((2,6-dimethylphenyl)imino-(2,2-dimethylpropylidene)molybdenum);bis(2,5-dimethylpyrrol-1-ide);1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol;2-[4-methyl-2,6-di(propan-2-yl)phenyl]-6-[2,4,6-tri(propan-2-yl)phenyl]phenol;pyrrol-1-ide;1,1,1-trifluoro-2-methylpropan-2-ol |
| SMILES | CC(C)(C)C=[Mo]=NC12CC3CC(CC(C3)C1)C2.CC(C)(C)C=[W]=Nc1c(Cl)cccc1Cl.CC(C)(O)C(F)(F)F.CC(O)(C(F)(F)F)C(F)(F)F.Cc1c(Br)cc2c(c1-c1c(O)c(Br)cc3c1CCCC3)CCCC2.Cc1c(Br)cc2c(c1-c1c(O)c(Br)cc3c1CCCC3)CCCC2.Cc1cc(C(C)C)c(-c2cccc(-c3c(C(C)C)cc(C(C)C)cc3C(C)C)c2O)c(C(C)C)c1.Cc1ccc(C)[n-]1.Cc1ccc(C)[n-]1.Cc1cccc(C)c1N=[Mo]=CC(C)(C)C.Cc1cccc(C)c1N=[Mo]=CC(C)(C)C.c1cc[n-]c1 |
| InChI | InChI=1S/C34H46O.2C21H22Br2O.C10H15N.2C8H9N.C6H3Cl2N.2C6H8N.4C5H10.C4H4F6O.C4H7F3O.C4H4N.3Mo.W/c1-19(2)25-17-30(22(7)8)33(31(18-25)23(9)10)27-14-12-13-26(34(27)35)32-28(20(3)4)15-24(11)16-29(32)21(5)6;2*1-12-17(22)10-13-6-2-4-8-15(13)19(12)20-16-9-5-3-7-14(16)11-18(23)21(20)24;11-10-4-7-1-8(5-10)3-9(2-7)6-10;2*1-6-4-3-5-7(2)8(6)9;7-4-2-1-3-5(8)6(4)9;2*1-5-3-4-6(2)7-5;4*1-5(2,3)4;1-2(11,3(5,6)7)4(8,9)10;1-3(2,8)4(5,6)7;1-2-4-5-3-1;;;;/h12-23,35H,1-11H3;2*10-11,24H,2-9H2,1H3;7-9H,1-6H2;2*3-5H,1-2H3;1-3H;2*3-4H,1-2H3;4*1H,2-4H3;11H,1H3;8H,1-2H3;1-4H;;;;/q;;;;;;;2*-1;;;;;;;-1;;;; |
| InChIKey | IBIASOOIRDZRCO-UHFFFAOYSA-N |
| XLogP | 47.21 |
| TPSA | 192.89 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 183 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3235.46 |
| LogP ≤ 5 | 47.21 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158430533 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.